Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab
Purpose. To evaluate the effects of pars plana vitrectomy (PPV) on recurrent macular edema due to branch retinal vein occlusion (BRVO) after intravitreal injections of bevacizumab (IVB). Methods. This retrospective study included 22 eyes of 22 patients who underwent single or multiple IVB injections...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2013/415974 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832567981022904320 |
---|---|
author | Tatsuya Yunoki Keiichi Mitarai Shuichiro Yanagisawa Tsuyoshi Kato Nobuo Ishida Atsushi Hayashi |
author_facet | Tatsuya Yunoki Keiichi Mitarai Shuichiro Yanagisawa Tsuyoshi Kato Nobuo Ishida Atsushi Hayashi |
author_sort | Tatsuya Yunoki |
collection | DOAJ |
description | Purpose. To evaluate the effects of pars plana vitrectomy (PPV) on recurrent macular edema due to branch retinal vein occlusion (BRVO) after intravitreal injections of bevacizumab (IVB). Methods. This retrospective study included 22 eyes of 22 patients who underwent single or multiple IVB injections for macular edema due to BRVO and showed a recurrence of macular edema. All patients then underwent PPV and were followed up for more than 6 months after the surgery with examinations of best corrected visual acuity (BCVA) and optical coherence tomography (OCT). OCT parameters were central macular thickness (CMT) and average retinal thickness in a 1-mm-diameter circular region at the fovea (MRT). Results. Mean BCVA, CRT, and MRT were significantly improved from the baseline after PPV. Greater improvement of BCVA, CRT, and MRT was obtained after 1 month of IVB than after 6 months of PPV. No eyes showed worsening of macular edema after the surgery. Conclusion. PPV improved BCVA and recurrent macular edema due to BRVO, but PPV that was less effective than IVB had been in the same patients. PPV may be one of the treatment options for recurrent macular edema due to BRVO after IVB. |
format | Article |
id | doaj-art-054ae0989b5047449a7d19632dbd5ca6 |
institution | Kabale University |
issn | 2090-004X 2090-0058 |
language | English |
publishDate | 2013-01-01 |
publisher | Wiley |
record_format | Article |
series | Journal of Ophthalmology |
spelling | doaj-art-054ae0989b5047449a7d19632dbd5ca62025-02-03T00:59:55ZengWileyJournal of Ophthalmology2090-004X2090-00582013-01-01201310.1155/2013/415974415974Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of BevacizumabTatsuya Yunoki0Keiichi Mitarai1Shuichiro Yanagisawa2Tsuyoshi Kato3Nobuo Ishida4Atsushi Hayashi5Department of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, JapanDepartment of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, JapanDepartment of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, JapanDivision of Ophthalmology, Takaoka Municipal Hospital, 4-1 Takaramachi, Takaoka 933-8550, JapanIshida Eye Clinic, 2-2-31 Honcho, Jouetsu 943-0832, JapanDepartment of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, JapanPurpose. To evaluate the effects of pars plana vitrectomy (PPV) on recurrent macular edema due to branch retinal vein occlusion (BRVO) after intravitreal injections of bevacizumab (IVB). Methods. This retrospective study included 22 eyes of 22 patients who underwent single or multiple IVB injections for macular edema due to BRVO and showed a recurrence of macular edema. All patients then underwent PPV and were followed up for more than 6 months after the surgery with examinations of best corrected visual acuity (BCVA) and optical coherence tomography (OCT). OCT parameters were central macular thickness (CMT) and average retinal thickness in a 1-mm-diameter circular region at the fovea (MRT). Results. Mean BCVA, CRT, and MRT were significantly improved from the baseline after PPV. Greater improvement of BCVA, CRT, and MRT was obtained after 1 month of IVB than after 6 months of PPV. No eyes showed worsening of macular edema after the surgery. Conclusion. PPV improved BCVA and recurrent macular edema due to BRVO, but PPV that was less effective than IVB had been in the same patients. PPV may be one of the treatment options for recurrent macular edema due to BRVO after IVB.http://dx.doi.org/10.1155/2013/415974 |
spellingShingle | Tatsuya Yunoki Keiichi Mitarai Shuichiro Yanagisawa Tsuyoshi Kato Nobuo Ishida Atsushi Hayashi Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab Journal of Ophthalmology |
title | Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab |
title_full | Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab |
title_fullStr | Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab |
title_full_unstemmed | Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab |
title_short | Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab |
title_sort | effects of vitrectomy on recurrent macular edema due to branch retinal vein occlusion after intravitreal injection of bevacizumab |
url | http://dx.doi.org/10.1155/2013/415974 |
work_keys_str_mv | AT tatsuyayunoki effectsofvitrectomyonrecurrentmacularedemaduetobranchretinalveinocclusionafterintravitrealinjectionofbevacizumab AT keiichimitarai effectsofvitrectomyonrecurrentmacularedemaduetobranchretinalveinocclusionafterintravitrealinjectionofbevacizumab AT shuichiroyanagisawa effectsofvitrectomyonrecurrentmacularedemaduetobranchretinalveinocclusionafterintravitrealinjectionofbevacizumab AT tsuyoshikato effectsofvitrectomyonrecurrentmacularedemaduetobranchretinalveinocclusionafterintravitrealinjectionofbevacizumab AT nobuoishida effectsofvitrectomyonrecurrentmacularedemaduetobranchretinalveinocclusionafterintravitrealinjectionofbevacizumab AT atsushihayashi effectsofvitrectomyonrecurrentmacularedemaduetobranchretinalveinocclusionafterintravitrealinjectionofbevacizumab |